Racial and Socioeconomic Disparities in Life Expectancy in America
Life expectancy by race in the United States in 2025 reveals one of the most persistent and measurable expressions of structural inequality in the country. Despite decades of medical progress and trillions spent on healthcare, a person's race and socioeconomic status remain strong predictors of how long they will live. The national average of approximately 78.9 years (2025 estimate) obscures a range that spans more than 16 years from the highest to the lowest racial/ethnic group — a gap wider than the difference between the United States and many lower-income countries.
This article brings together the latest available data from the CDC National Center for Health Statistics (NCHS), the U.S. Census Bureau, the Kaiser Family Foundation (KFF), and peer-reviewed research to provide a clear 2025 snapshot of life expectancy disparities, their underlying causes, and their policy implications.
At a glance: 2025 life expectancy snapshot
After steep declines during the COVID-19 pandemic (2020–2021), U.S. life expectancy has partially recovered. The 2023 CDC NCHS report — the latest available full-year data as of 2025 — shows a national average of approximately 78.4 years. Accounting for projected 2024–2025 improvement, the estimated current figure is around 78.9 years, bringing the national average back into roughly the same range as the pre-pandemic 2019 level once measurement differences are taken into account. Disparities by race, however, remain severe and have not recovered equally.
Pandemic aftermath: Between 2019 and 2021, AIAN life expectancy fell by nearly 10 years — the sharpest single-group decline recorded in modern U.S. public health history. By 2023 it had recovered only partially, to approximately 68.5 years. The Black population lost 4.5 years in the same period; recovery has been gradual.
Life expectancy by racial and ethnic group
The five major racial/ethnic groups tracked by the CDC NCHS show dramatically different life expectancy levels. These differences do not reflect biology or genetics — they reflect structural conditions including access to healthcare, historical discrimination, income inequality, environmental exposures, and systemic barriers to education and economic mobility.
Asian Americans have the highest life expectancy of any tracked group, driven by relatively higher educational attainment, higher median household income, lower rates of smoking, and greater access to preventive care. Important subgroup variation exists: Vietnamese, Hmong, and Pacific Islander populations have significantly shorter lifespans, underscoring that "Asian American" is not a monolithic category.
Despite higher rates of poverty and lower rates of health insurance than non-Hispanic Whites, Hispanic Americans live longer on average — a phenomenon called the "Hispanic Paradox" or "Epidemiological Paradox." Proposed explanations include strong family support networks, lower rates of smoking among certain subgroups, healthier dietary patterns among recent immigrants, and selective migration effects. The paradox weakens among subsequent generations.
Non-Hispanic White Americans sit close to the national average, but rural and low-income White communities have seen rising mortality from "deaths of despair" — opioid overdoses, alcohol-related liver disease, and suicide — that pulled this group's average down substantially since the early 2000s. States in Appalachia, the rural Midwest, and the Deep South show the most pronounced decline.
Black Americans experience disproportionate mortality from cardiovascular disease, hypertension, diabetes, and cancer — conditions shaped by systemic barriers including residential segregation, food deserts, occupational exposure to hazardous conditions, and chronic stress from discrimination. Even controlling for socioeconomic status, Black Americans face worse health outcomes than White Americans, demonstrating the independent role of structural racism. The Black–White gap narrowed in the 1990s–2000s but re-widened sharply during COVID-19 and has not fully recovered.
AIAN populations face the starkest life expectancy shortfall. This reflects the cumulative burden of historical dispossession, chronic underfunding of Indian Health Service (IHS) facilities, geographic isolation, high rates of diabetes, liver disease, suicide, and unintentional injuries, and limited healthcare infrastructure on many reservations. COVID-19 hit AIAN communities hardest of any group (2.8× higher death rate than White Americans), and while some recovery has occurred, the structural causes remain largely unaddressed.
Table 1. Life expectancy by race/ethnicity — United States, 2023 data & 2025 estimates
Figures based on CDC NCHS 2023 final and provisional data, with 2025 estimates from StatRanker harmonization. US national average life expectancy (2025 est.) = 78.9 years — used as the benchmark for gap calculations. Toggle Years / Gap to switch between absolute life expectancy and deviation from the national average.
| Group ↕ | Life Exp 2023 (yrs) ↓ | Est. 2025 (yrs) | Gap vs US avg ↕ | Change vs 2019 | Poverty rate | Uninsured rate |
|---|---|---|---|---|---|---|
| Asian American | 84.5 +5.6 yrs above avg | 84.8 | +5.9 yrs | −0.3 yrs | 8.8% | 6.2% |
| Hispanic / Latino | 80.0 +1.1 yrs above avg | 80.4 | +1.5 yrs | −2.4 yrs | 10.8% | 16.1% |
| Overall US Average | 78.4 baseline | 78.9 | baseline | −1.5 yrs | 11.5% | 9.2% |
| White (non-Hispanic) | 77.5 −1.4 yrs below avg | 77.8 | −1.1 yrs | −1.2 yrs | 8.6% | 5.9% |
| Black (non-Hispanic) | 72.8 −6.1 yrs below avg | 73.0 | −5.9 yrs | −3.5 yrs | 12.4% | 8.6% |
| American Indian / Alaska Native (AIAN) | 67.9 −11.0 yrs below avg | 68.5 | −10.4 yrs | −9.7 yrs | 25.4% | 14.9% |
Sources: CDC NCHS (2023 final data), U.S. Census Bureau ACS (poverty/uninsured), KFF Health Insurance Coverage. Change vs 2019 = difference in years between 2019 and 2023 data. Poverty and uninsured rates: 2022–2023 ACS data. Updated: May 2025.
Underlying causes of life expectancy disparities
Life expectancy gaps across racial and socioeconomic groups do not emerge from a single cause but from the compounding interaction of structural, environmental, and clinical factors that reinforce each other across generations. Research consistently identifies five primary driver categories.
1. Systemic racism and chronic stress
Structural racism — embedded in housing policy (redlining), education funding, criminal justice, and employment — shapes the environments, opportunities, and stresses experienced by Black, AIAN, and Hispanic Americans across their lifetimes. Chronic exposure to discrimination elevates allostatic load (cumulative biological stress), which is linked to higher rates of hypertension, cardiovascular disease, and accelerated cellular aging. A 2023 survey found that 20% of Black and Hispanic adults reported experiencing unfair treatment in healthcare settings in the past year.
2. Healthcare access and quality
Uninsured rates in 2023 remained significantly higher among Hispanic (16.1%), AIAN (14.9%), and Black (8.6%) populations than among White (5.9%) Americans. Beyond insurance, access to primary care physicians, hospitals, and specialist services is unevenly distributed geographically and economically. Indian Health Service — the primary federal healthcare provider for AIAN populations — is chronically underfunded, with per-capita spending approximately one-third that of other federal healthcare programs.
3. Social determinants of health
Income inequality, educational attainment, housing quality, food security, and environmental exposure (air and water pollution, proximity to industrial facilities) collectively account for an estimated 30–55% of health outcomes variation. Black Americans are more than twice as likely as White Americans to live in areas with elevated particulate air pollution. Food deserts — areas with low access to fresh, affordable food — disproportionately affect Black and AIAN communities.
4. Chronic disease burden
CDC data show substantially elevated mortality from preventable chronic diseases among Black and AIAN populations. Diabetes mortality per 100,000: Black Americans 42.9, AIAN 47.7, White Americans 21.3. Heart disease and hypertension are the leading killers of Black Americans, with rates roughly 40–50% higher than among White Americans. Hypertension prevalence among Black Americans (55%) is one of the highest rates recorded in any country worldwide.
5. COVID-19 and pandemic aftermath
The pandemic (2020–2022) amplified all existing disparities. AIAN people died from COVID-19 at 2.8 times the rate of White Americans; Black and Hispanic Americans faced 2.8 times higher hospitalisation rates. Structural factors — higher representation in essential worker roles, overcrowded housing, lower vaccine access during initial rollout, and medical distrust — drove these disparate outcomes. Long COVID disproportionately affects lower-income and minority populations, creating a lasting drag on workforce participation and chronic disease management.
Methodology
All figures in this article are derived from official public datasets and harmonized for comparability. No unpublished source data are used, and all 2025 estimates are simple extrapolations from public trend data. The methodology below describes data sourcing, processing choices, and key limitations.
| Dimension | Details |
|---|---|
| Primary indicator | Life expectancy at birth — the average number of years a newborn is expected to live if current mortality rates by age and sex remain constant throughout their lifetime. |
| Data year | Base figures: CDC NCHS 2023 final and provisional data (published December 2024). 2025 estimates are StatRanker projections extrapolated from the 2022–2023 trend. Historical comparison: 2019 CDC NCHS data used as the pre-pandemic baseline. |
| Racial/ethnic classification | CDC NCHS uses five categories: Asian American, Hispanic or Latino (any race), White non-Hispanic, Black non-Hispanic, and American Indian/Alaska Native. Multiracial and Native Hawaiian/Pacific Islander populations are tracked separately but not included in this table due to data reliability constraints for some sub-populations. |
| Sources | Life expectancy: CDC NCHS. Poverty rates: U.S. Census Bureau American Community Survey (ACS) 2022. Uninsured rates: Kaiser Family Foundation (KFF) Health Insurance Coverage data, 2023. Change vs 2019: comparison of CDC NCHS annual tables. |
| Processing and harmonisation | Figures are rounded to one decimal place. Gap values are calculated against a reference US average of 78.9 years (2025 estimate). Where CDC NCHS reports sex-specific tables, the average of male and female figures is used to produce an all-persons estimate. All values reflect all-cause mortality life expectancy, not cause-specific. |
| Limitations |
(1) Life expectancy is a period measure — it assumes current mortality rates continue unchanged, which may overstate or understate future outcomes. (2) Racial/ethnic categories are self-reported and imperfectly capture social identities. (3) Significant within-group variation exists (e.g., Vietnamese vs. Japanese Americans; urban vs. rural Black Americans) that group-level averages mask. (4) The "Hispanic Paradox" may partly reflect data artefacts such as return migration of ill individuals to countries of origin ("salmon bias"). (5) 2025 estimates are extrapolations and may differ from CDC NCHS figures once final 2024–2025 data are published. |
Insights: what the 2025 data tells us
1. Recovery from COVID-19 is uneven and slow
The pandemic devastated U.S. life expectancy across all groups, but the recovery has been sharply asymmetric. By 2023, Asian American and Hispanic populations had largely recovered their pre-pandemic trajectories. Black Americans showed modest recovery but remain 3–4 years below their 2019 level in most projections. AIAN populations — which fell by nearly 10 years between 2019 and 2021 — have recovered only about 1–2 years, suggesting deep structural barriers that cannot be overcome by the end of acute pandemic conditions alone.
2. The Black–White gap follows a decades-long pattern of incomplete closure
In 1900, the Black–White life expectancy gap in the United States was over 14 years. By 2019 it had narrowed to approximately 3.6 years — a historic achievement driven by improved access to healthcare, public health programs, and rising Black household incomes. COVID-19 reversed roughly a decade of progress in two years, pushing the gap back toward 6 years. This trajectory illustrates how structural progress is reversible when crises disproportionately exploit existing vulnerabilities.
3. Socioeconomic position does not fully protect minorities
Research demonstrates that Black Americans with college degrees and middle-class incomes still have worse health outcomes than White Americans with only high school education. This finding, replicated across multiple studies, demonstrates that racism operates as an independent risk factor beyond — and compounding — socioeconomic disadvantage. It challenges purely income-focused policy responses that ignore systemic discrimination in healthcare quality, neighborhood environments, and occupational exposure.
4. Geography is an underappreciated driver
The "Ten Americas" framework (Ezzati et al., updated in 2024) demonstrates that race interacts powerfully with geography to produce life expectancies that diverge by more than 20 years between sub-groups. Asian Americans in New England or California have very different life expectancy profiles from AIAN populations in the rural West or Southern Black Americans in deeply segregated counties. County-level analyses show life expectancy ranges of 20+ years across the United States — greater than the range across most developed countries. Zip code, in many analyses, predicts life expectancy better than any single clinical risk factor.
5. Preventable disease drives the gap more than exceptional mortality events
Most of the Black–White and AIAN–national gap is not driven by spectacular acute causes but by the cumulative accumulation of poorly managed chronic disease: hypertension, type 2 diabetes, chronic kidney disease, and cardiovascular disease. These conditions are highly preventable and manageable with adequate primary care access, healthy diet, exercise, and medication adherence — all factors shaped by income, education, neighbourhood environment, and health system access. This means that the gap is not inevitable: it is a policy choice.
6. The global context underscores the paradox of wealth
The United States spends more per capita on healthcare than any other developed nation (approximately $12,500 in 2023), yet its overall life expectancy ranks 47th globally. AIAN life expectancy (68.5 years) is comparable to countries with one-twentieth of U.S. per-capita income. Black American life expectancy (73.0 years) is lower than the national averages of Algeria, Honduras, and Vietnam. This paradox — great wealth, poor average outcomes, extreme internal inequality — reflects a health system structured around treatment rather than prevention, and markets rather than universal access.
What this means: interpretation and context
For individuals: Life expectancy statistics are population averages, not personal destiny. An individual's health outcomes depend on genetics, lifestyle, access to care, and many modifiable behaviours. However, the group-level data signal which communities face systemic tailwinds or headwinds — and awareness of those barriers is the first step toward better decisions and more effective advocacy.
For policymakers
These disparities are not a natural feature of a diverse society — they are the measurable outcome of specific policy choices over generations: where schools are funded, how housing is zoned, which communities receive infrastructure investment, and how healthcare is financed. Closing the gaps requires:
- Substantially increasing Indian Health Service funding toward parity with other federal health programs.
- Expanding Medicaid and marketplace subsidies to reduce uninsured rates among Hispanic and AIAN populations.
- Investing in place-based interventions — clean water, pollution control, food access — in communities with low life expectancy.
- Mandating collection and public reporting of race-stratified health outcome data at the hospital and insurer level.
- Addressing chronic disease management through community health worker programs scaled to reach underserved populations.
For healthcare professionals
Awareness of the structural causes of disparities should inform clinical practice. Race-conscious medicine — understanding how systemic factors, not biological race, shape patient risk — allows clinicians to identify when additional support, screening, or follow-up is warranted. Implicit bias training is associated with improved patient-provider communication and modestly better outcomes in minority populations.
For researchers
The most important next frontier is sub-group and geographic analysis. National-level racial averages obscure enormous within-group heterogeneity. Research linking neighborhood-level social determinants to individual health trajectories — using linked administrative data — offers the most granular picture of causation and the most precise levers for intervention.
For general readers
When you see claims that U.S. life expectancy is "similar to" or "catching up with" peer nations, check whether the comparison is to overall averages or to specific demographic sub-groups. A national average that improves while racial gaps widen represents a distributional failure, not health system success. Disaggregated data is a more reliable measure of progress.
FAQ: life expectancy and racial disparities in America
Primary data sources and references
All figures are drawn from publicly accessible, authoritative datasets. Users conducting formal analysis or policy work should access original databases and accompanying technical documentation directly.
All values in this article are rounded and harmonized for analytical comparability. For official country-level statistics, refer to the original sources above.
